Alt investors have opportunity to lead altimmune, inc. securities fraud lawsuit

New york , june 21, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of altimmune, inc. (nasdaq: alt) between december 1, 2023 and april 26, 2024, both dates inclusive (the "class period"), of the important july 5, 2024 lead plaintiff deadline. so what: if you purchased altimmune securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
ALT Ratings Summary
ALT Quant Ranking